United States
Germany
Japan
United Kingdom
China
Ccl19 (BC051472) Mouse Tagged ORF Clone Lentiviral Particle
CAT＃: MR200395L3V
- LentiORF®
-
Lenti ORF particles, Ccl19 (Myc-DDK-tagged) - Mouse chemokine (C-C motif) ligand 19 (cDNA clone MGC:62903 IMAGE:1349213), 200ul, >10^7 TU/mL
Need custom lentivirus service?
Get a free quote
CNY 6,650.00
货期*
详询
规格
Product images
经常一起买 (2)
Specifications
| Product Data | |
| Product Name | Ccl19 (BC051472) Mouse Tagged ORF Clone Lentiviral Particle |
| Synonyms | ELC, MIP3B, exodus-3, CKb11 |
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| ACCN | BC051472 |
| ORF Size | 324 bp |
| Sequence Data |
The ORF insert of this clone is exactly the same as(MR200395).
|
| OTI Disclaimer | The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info |
| OTI Annotation | This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene. |
| Reference Data | |
| RefSeq | BC051472, AAH51472 |
| RefSeq Size | 734 bp |
| RefSeq ORF | 326 bp |
| Locus ID | 24047 |
| Gene Summary | Strongly chemotactic for naive (L-selectinhi) CD4 T-cells and for CD8 T-cells and weakly attractive for resting B-cells and memory (L-selectinlo) CD4 T-cells. May play a role in promoting encounters between recirculating T-cells and dendritic cells and in the migration of activated B-cells into the T-zone of secondary lymphoid tissues. Binds to chemokine receptor CCR7. Binds to atypical chemokine receptor ACKR4 and mediates the recruitment of beta-arrestin (ARRB1/2) to ACKR4.[UniProtKB/Swiss-Prot Function] |
Documents
| Product Manuals |
| FAQs |
| SDS |
Resources
You may also need
Customer
Reviews
Loading...
